Lipodystrophy
by Jean Kressy, MS, RN, with Christine Wanke, MD, and Jül
Gerrior, RD
What is lipodystrophy?
Lipodystrophy, also called fat redistribution syndrome, is a
condition that often occurs in HIV-positive people and is characterized
by changes in body shape and metabolism. Body shape changes may
include the accumulation and/or loss of fat, which can affect
appearance. Metabolic changes may include increased resistance
to insulin and abnormally high levels of blood cholesterol and
triglycerides. These do not all necessarily occur together; each
may occur separately or in any combination. What causes lipodystrophy?
Health experts are not sure why HIV-positive people develop lipodystrophy,
but they think it may be related to antiretroviral medications
they take to control their disease. In addition to medications,
factors including a person’s age, gender, weight, genetic
predisposition, length of time he or she has been HIV-positive,
and severity of the disease may be linked to the development of
lipodystrophy. What body shape changes can occur with lipodystrophy?
Fat accumulation:
The most visible signs of lipodystrophy and the ones that people
may notice first are deposits of fat at various sites on their
bodies. The two places where fat generally accumulates are the
back of the neck (called ‘buffalo hump’) and around
the abdomen (truncal obesity). Increased breast size, especially
in women, may also occur. However, the changes in fat distribution
are not necessarily the same in everyone.
Fat loss:
Loss of body fat, called lipoatrophy, is another characteristic
of lipodystrophy that affects appearance. The most common places
where people lose fat are in their cheeks, making their faces
look thinner, and in their buttocks, arms and legs. When fat loss
occurs in the arms and legs, veins may be more visible.
The loss of body fat that occurs with lipodystrophy is not the
same as the weight loss that happens with wasting. People with
wasting lose weight as well as muscle and fat. In lipodystrophy,
there are alterations in body fat but not necessarily a change
in weight. Some people with lipodystrophy experience both fat
accumulation and fat loss. In some instances, body shape changes
may affect a person’s ability to perform daily activities,
such as exercising, sleeping, and even breathing.
What metabolic changes can occur with lipodystrophy?
Insulin resistance:
Insulin, a hormone produced by the pancreas, is responsible for
transporting sugar (also called glucose) from the blood into the
cells where it is used for energy. Normally after eating, the
amount of glucose in the blood increases; this signals the pancreas
to secrete insulin, which in turn prompts the cell to absorb the
glucose. In short, insulin is the substance that allows cells
to absorb glucose from the blood. Once it enters the cells, glucose
is used by the cells as fuel. In insulin resistance, either insulin
is not doing its job or the cells are unable to absorb glucose.
The result is that glucose may continue to rise in the blood,
and if not treated, can lead to diabetes. Insulin resistance may
be related to some of the antiretroviral medications used to treat
HIV, and/or to a genetic predisposition in the individual.
Dyslipidemia:
Dyslipidemia, or higher than normal amounts of lipids (cholesterol
and/or triglycerides) in the blood, is another metabolic change
which often occurs in HIV-positive people with lipodystrophy.
It also may be related to some of the antiretroviral medications
used to treat the disease, and/or to genetic predisposition.
In general, anyone with dyslipidemia may be more likely to develop
cardiovascular disease. However, studies show that unless HIV-infected
people with high blood lipids have other risks that increase heart
disease, such as smoking, obesity, or high blood pressure, their
chances of heart attack are no greater than HIV-negative people.
For more information about dyslipidemia and cardiovascular disease,
see the section on Cardiovascular Disease Risk.
How is lipodystrophy treated?
Although lipodystrophy includes a variety of body shape and metabolic
changes, a single intervention can often control more than one
symptom. For example, small research studies have shown that when
people with lipodystrophy eat more fiber, they may lose some abdominal
fat and may become less resistant to insulin. Exercise also provides
more than one benefit; in addition to losing fat, people who exercise
may have lower triglycerides and may be less insulin resistant.
Diet:
Instead of focusing on specific foods, some physicians advise
people with lipodystrophy to follow an eating plan based on the
Mediterranean diet. The diet, also recommended to healthy people
and those at risk for heart disease, is low in fat, especially
saturated fat, and refined sugars (such as candy, soft drinks,
cakes, cookies, ice cream) and alcohol, and high in fiber-rich
whole grains, fruits, and vegetables. Fat, especially saturated
fat, increases blood cholesterol and refined sugars, and alcohol
increase triglycerides. Fiber, on the other hand, may control
insulin resistance and may help decrease abdominal fat.
Nutrition experts say that the kind of fat eaten is as important
as the amount. Omega-3 fatty acids, for instance, are recommended,
but saturated fats (fatty meat, poultry with skin, butter, whole-milk
dairy foods, and coconut and palm oils) should be limited. In
addition to saturated fats, trans fats, found in some stick margarines
and Crisco, which are solid at room temperature, should be avoided.
Many packaged foods, especially baked goods, contain trans fats
to prolong their shelf lives. Read labels; if one of the ingredients
has the word ‘hydrogenated,’ it means it contains
trans fats. When choosing fats, look for tub or soft margarines,
which do not contain trans fats, and unsaturated oils like canola,
corn, and olive. Because fish is an excellent source of heart-healthy
omega-3 fatty acids, nutrition experts recommend eating fish regularly.
Although all seafood contains omega-3 fatty acids, the best sources
are fatty fish like salmon, albacore tuna, and mackerel.
Fiber and nutrient-packed whole-grains, legumes, and fruits and
vegetables, the cornerstones of Mediterranean eating, should play
leading roles in a healthful diet. If you’re not used to
eating fruits and vegetables, the recommended five servings of
fruits and/or vegetables a day may seem overwhelming—but
once you get into the habit, it’s very achievable. In addition
to snacking on fruits and eating vegetables and salads with meals,
fruits and vegetables are easy to add to everyday foods. For example,
slice a banana on breakfast toast or cereal, stir berries into
a cup of yogurt, layer sandwiches with tomato or roasted pepper,
stir a can of beans into a pot of vegetable soup or store-bought
spaghetti sauce, tweak the proportion of meat and vegetables in
a stew in favor of the vegetables, or make yourself a fruit smoothie.
When shopping for whole-grains, read labels and look for the words,
“bran” or “whole-grain” or “whole-wheat”
on the label.
See “Building
a High Quality Diet.”
See “Fiber content of selected
foods.”
See “Omega-3 fatty acids.”
Exercise:
Progressive resistance exercises (weight training), which are
recommended to build muscles in HIV-positive people with wasting,
may reduce triglycerides, decrease insulin resistance and decrease
abdominal fat in people with lipodystrophy. Regular weight lifting
and push-up routines, either in a gym or at home, are excellent,
but if this is not possible, incorporate activities like walking,
gardening or housecleaning into your day. Any activity that gets
you up and moving counts.
Aerobic exercises, which raise pulse rate and increase blood
flow to muscles, including the heart, are also recommended for
people with lipodystrophy. Moderate to vigorous aerobic exercise,
such as fast walking, running, or using a treadmill, combined
with resistance exercises, have increased strength and fitness,
improved blood cholesterol and insulin resistance, and reduced
fat in HIV-positive people without negatively affecting their
viral loads or CD4 counts.
For people who are not used to exercising, experts suggest they
start slowly and gradually increase the amount of the time they
exercise. For some people a regular routine works best; others
like to incorporate exercise into their daily schedules or to
combine it with a regular workout. The bottom line is to exercise
in any way that works for you. Anyone with concerns about cardiovascular
disease or over the age of 45 should consult with their physician
before beginning an exercise program.
Medications:
Although antiretroviral medications may be linked to the development
of lipodystrophy, there are no data that suggest that stopping
the medications improves body shape changes. Instead physicians
may recommend diet, exercise, and medicines targeted to the body
shape and metabolic changes associated with lipodystrophy.
Growth Hormone:
Growth hormone, used to treat HIV-positive people with wasting,
may also be given to people with lipodystrophy, although it is
not currently approved this use. In research studies, growth hormone
has successfully lowered blood triglycerides and reduced fat abdominal
fat and fat behind the neck. However, once growth hormone is stopped,
the abnormalities return. Furthermore, because growth hormone
may worsen insulin resistance, it’s not for everyone with
lipodystrophy. Investigators need to learn more about its safety
over a long time, and like all drugs, growth hormone has multiple
side effects.
Testosterone:
Because testosterone replacement has been used to reduce fat in
HIV-negative men, researchers are studying its potential for treating
lipodystrophy. However, at the moment it is not being used to
reverse the fat accumulation that occurs in lipodystrophy.
Metformin:
Metformin, which is used to treat diabetes, is also being prescribed
for people with lipodystrophy. In individuals with abnormal glucose
tolerance, metformin may improve insulin resistance, and may result
in weight loss, including abdominal fat loss. Other benefits may
include a drop in blood pressure and a decrease in blood triglycerides.
Patients taking metformin are monitored by their physicians for
side effects; there is particular concern about liver toxicity.
Anyone who is concerned that he or she may have changes associated
with lipodystrophy should discuss this with their healthcare provider.
It may be possible for them to refer you to an appropriate research
study or to a specialist who has an interest in the management
of the syndrome, if they do not have particular expertise in this
area.
|